Universal Ibogaine Announces Re-Opening of the Kelburn Recovery Center

2023-01-23T06:45:42-08:00January 23rd, 2023|Universal Ibogaine News|

Calgary, AB – TheNewswire - January 23, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it’s addiction and mental health treatment clinic, the Kelburn Recovery Center (“ Kelburn ”), which operates near Winnipeg, Manitoba via a wholly-owned subsidiary of UI, has re-opened effective January 23, 2023. Dr. [...]

Universal Ibogaine Highlights 2022 Accomplishments

2023-01-04T08:16:05-08:00January 4th, 2023|Universal Ibogaine News|

Calgary, AB – TheNewswire - January 4, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to transform the addiction treatment industry with medicalized ibogaine-centered care, is pleased to provide a year end summary of 2022 accomplishments. Nick Karos, Chief Executive Officer and board member of [...]

Universal Ibogaine Issues Common Shares Pursuant to Settlement of Claim

2023-01-04T08:19:21-08:00December 9th, 2022|Universal Ibogaine News|

Calgary, AB – TheNewswire - December 9, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, announces that it has agreed to issue 350,000 common shares (at a deemed price of $0.05) as part of a settlement agreement related to a claim filed in August 2021 by a [...]

Universal Ibogaine Undertaking Offering of Convertible Debt Securities and Common Shares

2023-01-04T08:18:27-08:00December 1st, 2022|Universal Ibogaine News|

Calgary, AB – December 1, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in process of finalizing an offering (the “ Offering ”) of convertible debt securities.  The Offering will consist of “Secured Guarantee Convertible Notes” (the “ Notes ”) which will bear interest at [...]

Universal Ibogaine Announces Closing of Private Placement

2023-01-04T08:17:37-08:00December 1st, 2022|Universal Ibogaine News|

Vancouver, BC / December 1, 2022 / Universal Ibogaine Inc. (the “Company”) (TSXV: IBO) is pleased to announce that it has closed its non-brokered private placement of convertible notes (the “Notes”) previously announced on October 3, 2022. (the “Debt Offering”) The Company has issued Notes in the aggregate principal amount of $626,500 CAD. The Notes shall mature 3 years from [...]

Universal Ibogaine Announces Formation of Advisory Board

2022-11-08T16:49:10-08:00November 8th, 2022|Universal Ibogaine News|

Calgary, AB – TheNewswire - November 08, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce the formation of an external Advisory Board as part of its strategic plans and mission to deliver medicalized ibogaine-centered addiction care and to undertake a planned clinical trial [...]

Universal Ibogaine Announces Results of Annual General Meeting

2022-10-05T19:45:48-07:00October 5th, 2022|Universal Ibogaine News|

Calgary, AB – TheNewswire - October 5, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce that all resolutions were passed by the requisite majority of shareholders at its annual general meeting (“ AGM ”) which was held on October 3, 2022 in Vancouver, BC. UI’s five incumbent [...]

Universal Ibogaine Undertaking Offering of Convertible Debt Securities and Common Shares

2022-10-03T20:46:24-07:00October 3rd, 2022|Universal Ibogaine News|

Calgary, AB – TheNewswire - October 3, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in process of finalizing an offering (the “ Offering ”) of convertible debt securities.  The Offering will consist of “Secured Guarantee Convertible Notes” (the “ Notes ”) which will bear interest at 8% (payable [...]

Universal Ibogaine Featured in Psychedelics Tonight Documentary Series

2022-09-27T14:58:58-07:00September 27th, 2022|Universal Ibogaine News|

Calgary, AB – TheNewswire - September 26 , 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce it has been featured in a documentary series entitled Psychedelics Tonight , which was co-produced by Kyle Buller and Joe Moore of Psychedelics Today in partnership with ALTRD.TV. The docuseries provides information on [...]

Universal Ibogaine Announces Kelburn Reopening Date

2022-09-23T20:06:27-07:00September 23rd, 2022|Universal Ibogaine News|

Calgary, AB – TheNewswire - September 22, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it’s research and development clinic, the Kelburn Mental Health and Addiction Recovery Center is scheduled to reopen and commence business operations on October 17, 2022 . Dr Ian Rabb, Universal Ibogaine Chief [...]

Go to Top